Compliance Officers Sample Clauses

Compliance Officers. The firm’s Compliance Officer for Legal Practice (‘COLP’) is: Xxxxxx Xxxxxx (xxxxxx.xxxxxx@xxxxx.xxx); and The firm’s Compliance Officer for Finance and Administration (‘COFA’) is: Xxxxxx Xxxxxx (xxxxxx.xxxxxx@xxxxx.xxx).
AutoNDA by SimpleDocs
Compliance Officers. “Compliance Officers” shall mean the persons employed as the Trial-Level Compliance Officer and the Juvenile Justice Compliance Officer by La. R.S. 15:157 and 15:158, respectively.
Compliance Officers. J&J Chief Compliance Officer. Prior to the Effective Date, J&J appointed a Covered Person to serve as its Chief Compliance Officer (hereafter “J&J Chief Compliance Officer” or “J&J CCO”). J&J shall maintain a J&J CCO for the term of the CIA. The J&J CCO shall be responsible for developing and implementing policies, procedures, and practices designed to ensure compliance with the requirements set forth in this CIA and with Federal health care program and FDA requirements. The J&J CCO shall be a member of senior management of J&J, shall make periodic (at least quarterly) reports directly to the Chief Executive Officer of J&J, shall make periodic (at least quarterly) reports regarding compliance matters directly to the Regulatory, Compliance, and Government Affairs Committee of the Board of Directors of J&J, and shall be authorized to report on such matters to the Regulatory, Compliance, and Government Affairs Committee of the Board of Directors at any time. The J&J CCO shall not be or be subordinate to the Chief Legal Officer or Chief Financial Officer. The J&J CCO shall be responsible for monitoring the day-to-day compliance activities engaged in by J&J as well as for any reporting obligations created under this CIA. Any noncompliance job responsibilities of the J&J CCO shall be limited and must not interfere with the J&J CCO’s ability to perform the duties outlined in this CIA. NALT Compliance Officer. Prior to the Effective Date, the J&J Pharmaceutical Affiliates, through their leadership board referred to as the J&J Pharmaceutical Group North American Leadership Team (NALT) appointed a Compliance Officer (NALT Compliance Officer), and the NALT shall maintain a Compliance Officer during the term of the CIA. The NALT Compliance Officer shall be responsible for working with the J&J CCO to develop and implement policies, procedures, and practices designed to ensure compliance with the requirements set forth in this CIA and with Federal health care program and FDA requirements. The NALT Compliance Officer shall be a member of senior management of the NALT and shall ensure periodic (at least quarterly) reports are made regarding compliance matters directly to the NALT, and shall be authorized to report on such matters to the NALT at any time. The NALT Compliance Officer also shall work with the J&J CCO to ensure periodic (at least quarterly) reports are made regarding compliance matters directly to the Regulatory, Compliance, and Government Affairs Committee o...
Compliance Officers. 1. Within 90 days after the Effective Date, TGS shall appoint a Chief Compliance Officer and shall maintain a Chief Compliance Officer for the term of the CIA. The Chief Compliance Officer shall be an employee and a member of senior management of TGS, shall report directly to the Chief Executive Officer of TGS, and shall not be or be subordinate to the General Counsel or Chief Financial Officer or have any responsibilities that involve acting in any capacity as legal counsel or supervising legal counsel functions for TGS. The Chief Compliance Officer shall be responsible for, without limitation:
Compliance Officers. Obligated people shall design a management authorities in charge of the obligations to which the second paragraph or article 19 of the Law is referred, in the term of two (2) months, from the in force of this Regulation, to whom they will denominate “compliance officers”. In case of the entities under the vigilance and inspection of the Superintendency of Banks, the term is of ten (10) days, from the same date, to confirm the designation of the officials; or, to design new officials that have the knowledge and experience to make the actions provided in the Law and this Regulation. The designation or confirmation of the compliance officers shall be informed to the Superintendency of Banks, through the Intendency, in the next ten (10) days. To such inform it shall be attached the curriculum vitae of the designed of confirmed official. Likewise, each time that a compliance officer is replaced, it shall be reported to the Superintendency of Banks, through the Intendency, and it has to be sent the curriculum vitae of the acting management authority, in the provided term. The compliance officers shall be exclusively dedicated to his or hers duties, except in case of the obligated people in Group B to which article 5 of this Regulation refers, which provides that the responsible of the compliance officer will be a management authority of such obligated people.
Compliance Officers. The board of directors of Affirm shall designate a “Chief Compliance Officerresponsible for Affirm’s CMS and all compliance-related activities and a “Bank Secrecy Act Officer” (who may be the same person as the Chief Compliance Officer). Such compliance officers shall have sufficient education and work experience to oversee the CMS and BSA Policy.

Related to Compliance Officers

  • Compliance Officer The Contractor shall employ a Compliance Officer who is accountable to the Contractor’s executive leadership and dedicated full-time to the Contractor’s Indiana Medicaid product lines. This individual will be the primary liaison with the State (or its designees) to facilitate communications between OMPP, the State’s contractors and the Contractor’s executive leadership and staff. This individual shall maintain a current knowledge of federal and state legislation, legislative initiatives and regulations that may impact the Hoosier Healthwise program. It is the responsibility of the Compliance Officer to coordinate reporting to the State as defined in Section 9 and to review the timeliness, accuracy and completeness of reports and data submissions to the State. The Compliance Officer, in close coordination with other key staff, has primary responsibility for ensuring all Contractor functions are in compliance with the terms of the Contract. The Compliance Officer shall meet with the OMPP Surveillance and Utilization Review Unit (SUR) on a quarterly basis.

  • Chief Compliance Officer The Chief Compliance Officer of the Trust will be responsible for administering its compliance policies and procedures, shall have sufficient authority and independence within the organization to compel others to adhere to the compliance policies and procedures, shall report directly to the Board of Trustees, shall annually furnish a written report on the operation of the compliance policies and procedures to the Board of Trustees and shall perform such other duties as prescribed by the Board of Trustees.

  • Compliance Audits D.4.1 Compliance Audit(s). Without limiting the generality of section A.7.4 (Records Review), if requested by the Province from time to time, which request shall be at the Province’s sole discretion, the Recipient, at its own expense, will forthwith retain an independent third party auditor to conduct one or more compliance audits of the Recipient or any Project. The audit will be conducted in accordance with Canadian Generally Accepted Auditing Standards, as adopted by the Canadian Institute of Chartered Accountants, applicable as of the date on which a record is kept or required to be kept under such standards. In addition, the audit will assess the Recipient’s compliance with the terms of the Agreement and will address, with respect to each Project, without limitation, the following:

  • Corporate Compliance Program Maintain, and will cause each other Loan Party to maintain on its behalf, a corporate compliance program reasonably acceptable to Agent. Until the Obligations have been Paid in Full, Borrower will modify such corporate compliance program from time to time (and cause the other Loan Parties and Subsidiaries to modify their respective corporate compliance programs) as may be reasonable to attempt to ensure continuing compliance in all material respects with all material applicable laws, ordinances, rules, regulations and requirements (including, in all applicable material respects, any material Health Care Laws). Borrower will permit Agent and/or any of its outside consultants to review such corporate compliance programs from time to time upon reasonable notice and during normal business hours of Borrower.

  • Compliance Monitoring Grantee must be subject to compliance monitoring during the period of performance in which funds are Expended and up to three years following the closeout of all funds. In order to assure that the program can be adequately monitored, the following is required of Grantee:

  • COMPLIANCE COMMITTEE (1) Within thirty (30) days of the date of this Agreement, the Board shall appoint a Compliance Committee of at least three (3) directors, of which no more than one (1) shall be an employee or controlling shareholder of the Bank or any of its affiliates (as the term “affiliate” is defined in 12 U.S.C. § 371c(b)(1)), or a family member of any such person. Upon appointment, the names of the members of the Compliance Committee and, in the event of a change of the membership, the name of any new member shall be submitted in writing to the Assistant Deputy Comptroller. The Compliance Committee shall be responsible for monitoring and coordinating the Bank's adherence to the provisions of this Agreement.

  • Compliance Review During the Term, Developer agrees to permit the GLO, HUD, and/or a designated representative of the GLO or HUD to access the Property for the purpose of performing Compliance-Monitoring Procedures. In accordance with GLO Compliance-Monitoring Procedures, the GLO or HUD will periodically monitor and audit Developer’s compliance with the requirements of this Agreement, the CDBG-DR Regulations, the CDBG Multifamily Rental Housing Guidelines, and any and all other Governmental Requirements during the Term. In conducting any compliance reviews, the GLO or HUD will rely primarily on information obtained from Developer’s records and reports, on-site monitoring, and audit reports. The GLO or HUD may also consider other relevant information gained from other sources, including litigation and citizen complaints. Attachment G GLO Contract No. 20-063-039-C547 5.04 HAZARDOUS MATERIALS: INDEMNIFICATION

  • Compliance Audit LEA shall have the right but shall be under no obligation to conduct audit(s), from time to time, of Provider’s records concerning its compliance obligations as set forth in this Article V. Provider shall make such records and other documents available to LEA upon request.

  • Policy Compliance Violations The Requester and Approved Users acknowledge that the NIH may terminate the DAR, including this Agreement and immediately revoke or suspend access to all controlled-access datasets subject to the NIH GDS Policy at any time if the Requester is found to be no longer in agreement with the principles outlined in the NIH GDS Policy, the terms described in this Agreement, or the Genomic Data User Code of Conduct. The Requester and PI agree to notify the NIH of any violations of the NIH GDS Policy, this Agreement, or the Genomic Data User Code of Conduct data within 24 hours of when the incident is identified. Repeated violations or unresponsiveness to NIH requests may result in further compliance measures affecting the Requester. The Requester and PI agree to notify the appropriate DAC(s) of any unauthorized data sharing, breaches of data security, or inadvertent data releases that may compromise data confidentiality within 24 hours of when the incident is identified. As permitted by law, notifications should include any known information regarding the incident and a general description of the activities or process in place to define and remediate the situation fully. Within 3 business days of the DAC notification(s), the Requester agrees to submit to the DAC(s) a detailed written report including the date and nature of the event, actions taken or to be taken to remediate the issue(s), and plans or processes developed to prevent further problems, including specific information on timelines anticipated for action. The Requester agrees to provide documentation verifying that the remediation plans have been implemented. Repeated violations or unresponsiveness to NIH requests may result in further compliance measures affecting the Requester. All notifications and written reports of data management incidents should be sent to the DAC(s) indicated in the Addendum to this Agreement. NIH, or another entity designated by NIH may, as permitted by law, also investigate any data security incident or policy violation. Approved Users and their associates agree to support such investigations and provide information, within the limits of applicable local, state, tribal, and federal laws and regulations. In addition, Requester and Approved Users agree to work with the NIH to assure that plans and procedures that are developed to address identified problems are mutually acceptable and consistent with applicable law.

  • Compliance Investigations Upon City’s request, Contractor agrees to provide to City, within sixty calendar days, a truthful and complete list of the names of all subcontractors, vendors, and suppliers that Contractor has used in the past five years on any of its contracts that were undertaken within San Diego County, including the total dollar amount paid by Contractor for each subcontract or supply contract. Contractor further agrees to fully cooperate in any investigation conducted by City pursuant to City's Nondiscrimination in Contracting Ordinance. Contractor understands and agrees that violation of this clause shall be considered a material breach of the Contract and may result in Contract termination, debarment, and other sanctions.

Time is Money Join Law Insider Premium to draft better contracts faster.